{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:55:55Z","timestamp":1773305755233,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1657,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007110","name":"Schering-Plough","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007920","name":"University of Massachusetts Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004439","name":"William and Flora Hewlett Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004439","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.jcin.2008.09.010","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T15:40:44Z","timestamp":1232552444000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Reperfusion in Patients With Renal Dysfunction After Presentation With ST-Segment Elevation or Left Bundle Branch Block"],"prefix":"10.1016","volume":"2","author":[{"given":"Caroline","family":"Medi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Budaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith A.A.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"L\u00f3pez-Send\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Brieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2008.09.010_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcin.2008.09.010_bib2","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.CIR.0000027560.41358.B3","article-title":"Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes","volume":"106","author":"Al Suwaidi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2008.09.010_bib3","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.161.6.886","article-title":"High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension","volume":"161","author":"Schillaci","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcin.2008.09.010_bib4","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/ehi880","article-title":"Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women form the general population","volume":"27","author":"Meisinger","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2008.09.010_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.mnh.0000222698.30207.aa","article-title":"Epidemiology of non dialysis-requiring chronic kidney disease and cardiovascular disease","volume":"15","author":"Go","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jcin.2008.09.010_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.ajkd.2005.10.029","article-title":"Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with chronic kidney disease","volume":"47","author":"Martinez-Vera","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcin.2008.09.010_bib7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000095301","article-title":"Glomerular filtration rate on admission independently predicts short term in-hospital mortality after acute myocardial infarction","volume":"26","author":"Afshinnia","year":"2006","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jcin.2008.09.010_bib8","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2008.09.010_bib9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1067\/mhj.2002.125504","article-title":"Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction","volume":"144","author":"Walsh","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2008.09.010_bib10","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/01.CIR.0000143629.55725.D9","article-title":"Survival after coronary revascularization among patients with kidney disease","volume":"110","author":"Hemmelgarn","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2008.09.010_bib11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ahj.2004.10.010","article-title":"Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS)","volume":"149","author":"Ix","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2008.09.010_bib12","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/01.CIR.0000016051.33225.33","article-title":"Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation","volume":"105","author":"Szczech","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2008.09.010_bib13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.296.11.1377","article-title":"Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease","volume":"296","author":"Coca","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2008.09.010_bib14","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1161\/01.CIR.102.24.2966","article-title":"Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?","volume":"102","author":"Rubenstein","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2008.09.010_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/j.ajkd.2005.06.008","article-title":"Delay in time to receipt of thrombolytic medication among Medicare patients with kidney disease","volume":"46","author":"Newsome","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcin.2008.09.010_bib16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1067\/mhj.2001.112404","article-title":"Rationale and design of the GRACE (Global Registry of ACute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes","volume":"141","author":"Investigators","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2008.09.010_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0002-9149(02)02489-X","article-title":"Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)","volume":"90","author":"Steg","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2008.09.010_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2004.03.027","article-title":"Validation of the modification of diet in renal disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay","volume":"44","author":"Hallan","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcin.2008.09.010_bib19","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Predictors of hospital mortality in the Global Registry of Acute Coronary Events","volume":"163","author":"Granger","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcin.2008.09.010_bib20","doi-asserted-by":"crossref","first-page":"353A","DOI":"10.1016\/S0735-1097(03)82099-5","article-title":"A robust prediction model for all forms of acute coronary syndromes: estimating the risk of in-hospital death and myocardial infarction in the Global Registry of Acute Coronary Events Registry","volume":"41","author":"Eagle","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2008.09.010_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0735-1097(00)00774-9","article-title":"Risks associated with renal dysfunction in patients in the coronary care unit","volume":"36","author":"McCullough","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2008.09.010_bib22","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1053\/ajkd.2001.24522","article-title":"Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction","volume":"37","author":"Beattie","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcin.2008.09.010_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/hrt.2005.084830","article-title":"Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics?","volume":"93","author":"Fox","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2008.09.010_bib24","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.107.696765","article-title":"Clinical characteristics of dialysis patients with acute myocardial infarctions in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction","volume":"116","author":"Herzog","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2008.09.010_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5414\/CNP64412","article-title":"Risk of bleeding and restenosis among chronic kidney disease patients undergoing percutaneous coronary intervention","volume":"64","author":"Attallah","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jcin.2008.09.010_bib26","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/CIRCULATIONAHA.107.694273","article-title":"Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?","volume":"116","author":"Spencer","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2008.09.010_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jacc.2004.04.034","article-title":"Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: systematic overview and meta-analysis of randomized trials","volume":"44","author":"Agostoni","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2008.09.010_bib28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1056\/NEJMoa052711","article-title":"Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention","volume":"355","author":"Montalescot","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2008.09.010_bib29","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1001\/archinte.167.22.2423","article-title":"Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary interventions: quantitative review or randomized trials","volume":"167","author":"Dumaine","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcin.2008.09.010_bib30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2008.09.010_bib31","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial","volume":"49","author":"Manoukian","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2008.09.010_bib32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/archinte.167.1.68","article-title":"External validity of clinical trials in acute myocardial infarction","volume":"167","author":"Steg","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcin.2008.09.010_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9149(03)00716-1","article-title":"Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes","volume":"92","author":"Keeley","year":"2003","journal-title":"Am J Cardiol"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879808004457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879808004457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:55:37Z","timestamp":1761846937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879808004457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1936879808004457"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2008.09.010","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reperfusion in Patients With Renal Dysfunction After Presentation With ST-Segment Elevation or Left Bundle Branch Block","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2008.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}